Prosecution Insights
Last updated: October 25, 2026

Keisen Associates

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering

7 pending office actions • 7 clients • 7 examiners • 7 art units • 0 of 7 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Analysis

Keisen Associates focuses on Biotechnology & Pharmaceuticals and reports 8 pending office actions across 285 career applications. These figures show current prosecution activity against the firm’s recorded application base.

The resolved allowance rate is 88.66%, and the average is 2.2 office actions per allowance. Practitioners can use the two measures together to evaluate resolved results and the amount of office-action activity connected with allowances.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=285 apps, methodology: how we score firms)

88.7%
Allowance Rate
n=285
+0.51σ
Allowance Rate (norm)
n=285
2.2
OAs to Allowance
n=211
-0.77σ
OAs to Allow (norm)
n=211
975 days
Time to Allowance
n=211
+5.1pp
Interview Lift
n=285
13.4%
RCE Rate
n=285
0.7%
Appeal Rate
n=285

Rejection Performance (% of received rejections ultimately overcome)

70.4%
§101 Overcome
n=27
78.1%
§102 Overcome
n=64
75.2%
§103 Overcome
n=109
79.1%
§112 Overcome
n=115

Specialization & Scale

G06F, A61B, A61K
Top CPC Subclasses
12%
Top-3 CPC Share
n=285
2
Practitioners
n=285
142.5
Apps / Practitioner
n=285

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (71%)
2
Medium (29%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (29%)
§103 only1 (14%)
§102 only1 (14%)
Multi-statute (no §101)3 (43%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
57% of docket
0
Information Tech
0% of docket
1
Communications
14% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
29% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HAGOPIAN, CASEY SHEA 1 54.3% +33.4%
GARCIA, SANTIAGO 1 87.9% +13.6%
AFREMOVA, VERA 1 50.5% +29.4%
COCHRAN, KARI LEE 1 100.0% +0.0%
DO, NHAT CHIEU Q 1 64.0% +48.7%
NERANGIS, VICKEY M 1 56.6% +28.9%
DOWNES, NATHANAEL JASON 1 62.9% +15.7%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18867537 Formulation of lecithin-modified calcium phosphate nanoparticles with an enhanced cellar uptake as a carrier for bisphosphonates and a method of preparing thereof HAGOPIAN, CASEY SHEA —
18843172 A METHOD OF DETECTION OF A LANDMARK IN A VOLUME OF MEDICAL IMAGES GARCIA, SANTIAGO —
18726183 FUNCTIONAL FOOD CONTAINING BONITO-DERIVED EXTRACT FOR PREVENTING OR AMELIORATING NEUROPSYCHIATRIC DISORDERS AFREMOVA, VERA —
18719380 Porous-Based Bone Replacement Materials Formed By Triply Periodic Minimal Surface Structure COCHRAN, KARI LEE —
18707861 WATER SUPPLY DEVICE FOR BLADE DO, NHAT CHIEU Q —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18867537 Formulation of lecithin-modified calcium phosphate nanoparticles with an enhanced cellar uptake as a carrier for bisphosphonates and a method of preparing thereof HAGOPIAN, CASEY SHEA —
18843172 A METHOD OF DETECTION OF A LANDMARK IN A VOLUME OF MEDICAL IMAGES GARCIA, SANTIAGO —
18726183 FUNCTIONAL FOOD CONTAINING BONITO-DERIVED EXTRACT FOR PREVENTING OR AMELIORATING NEUROPSYCHIATRIC DISORDERS AFREMOVA, VERA —
18707861 WATER SUPPLY DEVICE FOR BLADE DO, NHAT CHIEU Q —
18579153 A METHOD FOR PREPARING HYALURONIC ACID GRAFTED POLY(N-ISOPROPYLACRYLAMIDE) (HA-G-PNI-PAM) NERANGIS, VICKEY M —
18254940 HYDROGEN PRODUCTION METHOD AND DEVICE DOWNES, NATHANAEL JASON —

Client Portfolio (7 clients)

Top Art Units

Art UnitApps
16171
26731
16531
37741
37241
17631
17941

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18867537 Formulation of lecithin-modified calcium phosphate nanoparticles with an enhanced cellar uptake as a carrier for bisphosphonates and a method of preparing thereof Politechnika Warszawska HAGOPIAN, CASEY SHEA 1617 §103§112 Non-Final OA — Pending Nov 20, 2024
18843172 A METHOD OF DETECTION OF A LANDMARK IN A VOLUME OF MEDICAL IMAGES Hemolens Diagnostics Spólka Z Ograniczona Odpowiedzialnoscia GARCIA, SANTIAGO 2673 §101§103 Non-Final OA — Pending Aug 30, 2024
18726183 FUNCTIONAL FOOD CONTAINING BONITO-DERIVED EXTRACT FOR PREVENTING OR AMELIORATING NEUROPSYCHIATRIC DISORDERS Nippon Medical School Foundation AFREMOVA, VERA 1653 §101§102§103 Final Rejection — Pending Jul 02, 2024
18719380 Porous-Based Bone Replacement Materials Formed By Triply Periodic Minimal Surface Structure Patcharapit Promoppatum COCHRAN, KARI LEE 3774 §103§112 Non-Final OA — Pending Jun 13, 2024
18707861 WATER SUPPLY DEVICE FOR BLADE Mikasa Sangyo Co., Ltd. DO, NHAT CHIEU Q 3724 §103§112 Final Rejection — Pending May 06, 2024
18579153 A METHOD FOR PREPARING HYALURONIC ACID GRAFTED POLY(N-ISOPROPYLACRYLAMIDE) (HA-G-PNI-PAM) Nabsolute Company Limited NERANGIS, VICKEY M 1763 §103 Non-Final OA — Pending Jan 12, 2024
18254940 HYDROGEN PRODUCTION METHOD AND DEVICE Instytut Niskich Temperatur I Badan Strukturalnych Pan Im.W.Trzebiatowskiego DOWNES, NATHANAEL JASON 1794 §102 Non-Final OA — Pending May 30, 2023

Managing Keisen Associates's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Keisen Associates's patent allowance rate?

88.7% of resolved applications prosecuted by Keisen Associates were allowed, across 285 applications in USPTO records.

How many office actions does Keisen Associates average before allowance?

2.20 office actions per allowed application on average.

How many pending office actions does Keisen Associates have?

7 pending office actions as of October 2026, for 7 clients, before 7 examiners in 7 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month